应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
KPTI Karyopharm Therapeutics Inc.
休市中 07-11 16:00:00 EDT
4.55
-0.45
-9.00%
盘后
4.30
-0.25
-5.49%
19:51 EDT
最高
4.58
最低
3.70
成交量
174.37万
今开
4.19
昨收
5.00
日振幅
17.66%
总市值
3,931万
流通市值
3,589万
总股本
863.99万
成交额
710.36万
换手率
22.11%
流通股本
788.71万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨6.86%报5.14美元
市场透视 · 07-10
Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨6.86%报5.14美元
Karyopharm Therapeutics Inc.盘中异动 早盘快速下跌6.36%报4.35美元
市场透视 · 05-23
Karyopharm Therapeutics Inc.盘中异动 早盘快速下跌6.36%报4.35美元
Karyopharm Therapeutics Inc.盘中异动 股价大跌5.33%报4.88美元
市场透视 · 05-21
Karyopharm Therapeutics Inc.盘中异动 股价大跌5.33%报4.88美元
Karyopharm Therapeutics Inc.盘中异动 快速下挫5.08%报5.05美元
市场透视 · 05-19
Karyopharm Therapeutics Inc.盘中异动 快速下挫5.08%报5.05美元
Karyopharm Therapeutics Inc.2025财年第一财季实现净利润-23.46百万美元,同比增加37.21%
市场透视 · 05-18
Karyopharm Therapeutics Inc.2025财年第一财季实现净利润-23.46百万美元,同比增加37.21%
Karyopharm Therapeutics Inc.盘中异动 快速拉升5.15%
市场透视 · 05-15
Karyopharm Therapeutics Inc.盘中异动 快速拉升5.15%
加拿大皇家银行:维持Karyopharm Therapeutics(KPTI.US)评级,由优于大市调整至优于大市评级, 目标价由34.00美元调整至33.00美元。
金融界 · 05-13
加拿大皇家银行:维持Karyopharm Therapeutics(KPTI.US)评级,由优于大市调整至优于大市评级, 目标价由34.00美元调整至33.00美元。
Karyopharm Therapeutics Inc.盘中异动 早盘股价大跌6.82%报5.60美元
市场透视 · 05-12
Karyopharm Therapeutics Inc.盘中异动 早盘股价大跌6.82%报5.60美元
Karyopharm Therapeutics Inc.盘中异动 早盘急速拉升6.10%
市场透视 · 05-09
Karyopharm Therapeutics Inc.盘中异动 早盘急速拉升6.10%
Karyopharm Therapeutics Inc.盘中异动 股价大涨6.25%报7.82美元
市场透视 · 05-05
Karyopharm Therapeutics Inc.盘中异动 股价大涨6.25%报7.82美元
Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨7.62%
市场透视 · 05-02
Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨7.62%
Karyopharm Therapeutics Inc.盘中异动 股价大涨5.51%报6.70美元
市场透视 · 04-30
Karyopharm Therapeutics Inc.盘中异动 股价大涨5.51%报6.70美元
Karyopharm Therapeutics Inc.盘中异动 临近午盘大幅上涨5.06%报6.38美元
市场透视 · 04-29
Karyopharm Therapeutics Inc.盘中异动 临近午盘大幅上涨5.06%报6.38美元
Karyopharm Therapeutics Inc.盘中异动 早盘急速拉升7.47%报6.04美元
市场透视 · 04-28
Karyopharm Therapeutics Inc.盘中异动 早盘急速拉升7.47%报6.04美元
Karyopharm Therapeutics Inc.盘中异动 股价大跌6.20%报5.60美元
市场透视 · 04-25
Karyopharm Therapeutics Inc.盘中异动 股价大跌6.20%报5.60美元
Karyopharm Therapeutics Inc.盘中异动 急速下挫5.58%
市场透视 · 04-24
Karyopharm Therapeutics Inc.盘中异动 急速下挫5.58%
Karyopharm Therapeutics Inc.盘中异动 急速上涨5.56%报5.70美元
市场透视 · 04-22
Karyopharm Therapeutics Inc.盘中异动 急速上涨5.56%报5.70美元
Karyopharm Therapeutics Inc.盘中异动 早盘急速拉升6.06%
市场透视 · 04-21
Karyopharm Therapeutics Inc.盘中异动 早盘急速拉升6.06%
Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨6.11%报4.69美元
市场透视 · 04-17
Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨6.11%报4.69美元
Karyopharm Therapeutics Inc.盘中异动 大幅上涨5.75%报4.51美元
市场透视 · 04-16
Karyopharm Therapeutics Inc.盘中异动 大幅上涨5.75%报4.51美元
加载更多
公司概况
公司名称:
Karyopharm Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Karyopharm Therapeutics Inc.于2008年12月22日在特拉华州注册成立。该公司是一家临床阶段的制药公司,专注于发现和开发针对核转运靶点的新型一线药物,用于治疗癌症和重大疾病。该公司的科学专长集中在了解细胞核和细胞质之间细胞内运输的调节。该公司发现并开发了抑制核输出蛋白XPO1的全资、新型、小分子、核输出选择性抑制剂或SINE化合物。该公司的主要候选药物Selinexor(KPT-330)是一种XPO1抑制剂,正在多个开放标签的1期临床试验中接受评估,这些试验针对的是经过深度预处理的复发和难治性血液系统和实体瘤恶性肿瘤患者。
发行价格:
--
{"stockData":{"symbol":"KPTI","market":"US","secType":"STK","nameCN":"Karyopharm Therapeutics Inc.","latestPrice":4.55,"timestamp":1752264000000,"preClose":5,"halted":0,"volume":1743718,"hourTrading":{"tag":"盘后","latestPrice":4.3,"preClose":4.55,"latestTime":"19:51 EDT","volume":11109,"amount":49771.774,"timestamp":1752277870384},"delay":0,"floatShares":7887089,"shares":8639904,"eps":-12.56363,"marketStatus":"休市中","change":-0.45,"latestTime":"07-11 16:00:00 EDT","open":4.19,"high":4.58,"low":3.6971,"amount":7103633.3682740005,"amplitude":0.17658,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-12.56363,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1383714000000,"exchange":"NASDAQ","adjPreClose":5,"preHourTrading":{"tag":"盘前","latestPrice":4.17,"preClose":5,"latestTime":"09:29 EDT","volume":88740,"amount":424490.98464,"timestamp":1752240577085},"postHourTrading":{"tag":"盘后","latestPrice":4.3,"preClose":4.55,"latestTime":"19:51 EDT","volume":11109,"amount":49771.774,"timestamp":1752277870384},"volumeRatio":21.899237173172516,"impliedVol":1.5871,"impliedVolPercentile":0.5382},"requestUrl":"/m/hq/s/KPTI","defaultTab":"news","newsList":[{"id":"2550774621","title":"Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨6.86%报5.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550774621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550774621?lang=zh_cn&edition=full","pubTime":"2025-07-10 23:04","pubTimestamp":1752159873,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日23时04分,Karyopharm Therapeutics Inc.股票出现异动,股价大幅上涨6.86%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.78%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071023043397a11ad7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071023043397a11ad7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","KPTI","BK4539"],"gpt_icon":0},{"id":"2537371201","title":"Karyopharm Therapeutics Inc.盘中异动 早盘快速下跌6.36%报4.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537371201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537371201?lang=zh_cn&edition=full","pubTime":"2025-05-23 22:19","pubTimestamp":1748009999,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日22时19分,Karyopharm Therapeutics Inc.股票出现异动,股价急速下跌6.36%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523221959a489cfb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523221959a489cfb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","KPTI","BK4539"],"gpt_icon":0},{"id":"2537930181","title":"Karyopharm Therapeutics Inc.盘中异动 股价大跌5.33%报4.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537930181","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537930181?lang=zh_cn&edition=full","pubTime":"2025-05-22 00:23","pubTimestamp":1747844617,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日00时23分,Karyopharm Therapeutics Inc.股票出现异动,股价快速下跌5.33%。截至发稿,该股报4.88美元/股,成交量1.1512万股,换手率0.13%,振幅4.07%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.38%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522002338a6e7ae45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522002338a6e7ae45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","BK4539","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2536915639","title":"Karyopharm Therapeutics Inc.盘中异动 快速下挫5.08%报5.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536915639","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536915639?lang=zh_cn&edition=full","pubTime":"2025-05-20 00:28","pubTimestamp":1747672084,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日00时28分,Karyopharm Therapeutics Inc.股票出现异动,股价快速跳水5.08%。截至发稿,该股报5.05美元/股,成交量1.559万股,换手率0.18%,振幅4.51%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.19%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520002805a6e4f75b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520002805a6e4f75b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","BK4139","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2536594163","title":"Karyopharm Therapeutics Inc.2025财年第一财季实现净利润-23.46百万美元,同比增加37.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536594163","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536594163?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:01","pubTimestamp":1747584062,"startTime":"0","endTime":"0","summary":"5月19日,Karyopharm Therapeutics Inc.公布财报,公告显示公司2025财年第一财季净利润为-23.46百万美元,同比增加37.21%;其中营业收入为30.02百万美元,同比减少9.39%,每股基本收益为-2.77美元。机构评级:截至2025年5月19日,当前有7家机构对Karyopharm Therapeutics Inc.目标价做出预测,其中目标均价为33.07美元,其中最低目标价为8.00美元,最高目标价为67.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000332a6e3a7c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000332a6e3a7c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","LENZ"],"gpt_icon":0},{"id":"2535821307","title":"Karyopharm Therapeutics Inc.盘中异动 快速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535821307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535821307?lang=zh_cn&edition=full","pubTime":"2025-05-15 21:46","pubTimestamp":1747316789,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时46分,Karyopharm Therapeutics Inc.股票出现波动,股价快速上涨5.15%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。该信息摘要如下:加拿大皇家银行:维持Karyopharm Therapeutics评级,由优于大市调整至优于大市评级, 目标价由34.00美元调整至33.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515214629a47faa17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515214629a47faa17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4539","BK4007","KPTI"],"gpt_icon":0},{"id":"2535000067","title":"加拿大皇家银行:维持Karyopharm Therapeutics(KPTI.US)评级,由优于大市调整至优于大市评级, 目标价由34.00美元调整至33.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535000067","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535000067?lang=zh_cn&edition=full","pubTime":"2025-05-14 01:32","pubTimestamp":1747157573,"startTime":"0","endTime":"0","summary":"加拿大皇家银行:维持Karyopharm Therapeutics(KPTI.US)评级,由优于大市调整至优于大市评级, 目标价由34.00美元调整至33.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/14013250362341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","KPTI"],"gpt_icon":0},{"id":"2534321205","title":"Karyopharm Therapeutics Inc.盘中异动 早盘股价大跌6.82%报5.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534321205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534321205?lang=zh_cn&edition=full","pubTime":"2025-05-12 22:47","pubTimestamp":1747061279,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日22时47分,Karyopharm Therapeutics Inc.股票出现波动,股价快速跳水6.82%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为2.85%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512224759aa2c8ba2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512224759aa2c8ba2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","LENZ","BK4139","KPTI"],"gpt_icon":0},{"id":"2534480581","title":"Karyopharm Therapeutics Inc.盘中异动 早盘急速拉升6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534480581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534480581?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:36","pubTimestamp":1746797769,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时36分,Karyopharm Therapeutics Inc.股票出现波动,股价大幅拉升6.10%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.58%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509213609a4783e34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509213609a4783e34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LENZ","BK4007","KPTI"],"gpt_icon":0},{"id":"2533802565","title":"Karyopharm Therapeutics Inc.盘中异动 股价大涨6.25%报7.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533802565","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533802565?lang=zh_cn&edition=full","pubTime":"2025-05-05 21:48","pubTimestamp":1746452918,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日21时48分,Karyopharm Therapeutics Inc.股票出现异动,股价急速上涨6.25%。截至发稿,该股报7.82美元/股,成交量1.5185万股,换手率0.18%,振幅4.55%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.41%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505214838974fa460&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505214838974fa460&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","KPTI"],"gpt_icon":0},{"id":"2532884065","title":"Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨7.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532884065","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532884065?lang=zh_cn&edition=full","pubTime":"2025-05-02 22:00","pubTimestamp":1746194418,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日22时00分,Karyopharm Therapeutics Inc.股票出现波动,股价大幅拉升7.62%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.23%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502220019a470096c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502220019a470096c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2532050290","title":"Karyopharm Therapeutics Inc.盘中异动 股价大涨5.51%报6.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532050290","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532050290?lang=zh_cn&edition=full","pubTime":"2025-04-30 23:56","pubTimestamp":1746028593,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日23时56分,Karyopharm Therapeutics Inc.股票出现波动,股价大幅拉升5.51%。截至发稿,该股报6.70美元/股,成交量1.9767万股,换手率0.23%,振幅6.22%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.91%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043023563494e923e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043023563494e923e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2531765310","title":"Karyopharm Therapeutics Inc.盘中异动 临近午盘大幅上涨5.06%报6.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531765310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531765310?lang=zh_cn&edition=full","pubTime":"2025-04-29 23:46","pubTimestamp":1745941576,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日23时46分,Karyopharm Therapeutics Inc.股票出现异动,股价快速上涨5.06%。截至发稿,该股报6.38美元/股,成交量1.9663万股,换手率0.23%,振幅7.58%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.56%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429234616974a61ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429234616974a61ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","KPTI"],"gpt_icon":0},{"id":"2530236389","title":"Karyopharm Therapeutics Inc.盘中异动 早盘急速拉升7.47%报6.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530236389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530236389?lang=zh_cn&edition=full","pubTime":"2025-04-28 23:13","pubTimestamp":1745853236,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日23时13分,Karyopharm Therapeutics Inc.股票出现波动,股价快速上涨7.47%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为1.03%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428231356aa2c7d29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428231356aa2c7d29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2530139934","title":"Karyopharm Therapeutics Inc.盘中异动 股价大跌6.20%报5.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530139934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530139934?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:31","pubTimestamp":1745587862,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时31分,Karyopharm Therapeutics Inc.股票出现异动,股价快速跳水6.20%。截至发稿,该股报5.60美元/股,成交量6128股,换手率0.07%,振幅0.00%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.32%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042521310297451768&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042521310297451768&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","BK4139","LENZ","BK4007"],"gpt_icon":0},{"id":"2530695061","title":"Karyopharm Therapeutics Inc.盘中异动 急速下挫5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530695061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530695061?lang=zh_cn&edition=full","pubTime":"2025-04-25 00:45","pubTimestamp":1745513107,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日00时45分,Karyopharm Therapeutics Inc.股票出现波动,股价急速下跌5.58%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.54%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504250045079743db55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504250045079743db55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","KPTI","LENZ","BK4139"],"gpt_icon":0},{"id":"2529537991","title":"Karyopharm Therapeutics Inc.盘中异动 急速上涨5.56%报5.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529537991","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529537991?lang=zh_cn&edition=full","pubTime":"2025-04-23 00:59","pubTimestamp":1745341179,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日00时59分,Karyopharm Therapeutics Inc.股票出现异动,股价快速上涨5.56%。截至发稿,该股报5.70美元/股,成交量2.9037万股,换手率0.34%,振幅4.44%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为2.09%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230059409740eaca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504230059409740eaca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","KPTI"],"gpt_icon":0},{"id":"2529800241","title":"Karyopharm Therapeutics Inc.盘中异动 早盘急速拉升6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529800241","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529800241?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:18","pubTimestamp":1745245133,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时18分,Karyopharm Therapeutics Inc.股票出现波动,股价快速拉升6.06%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.17%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421221853aa2c7450&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421221853aa2c7450&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","KPTI"],"gpt_icon":0},{"id":"2528728747","title":"Karyopharm Therapeutics Inc.盘中异动 早盘股价大涨6.11%报4.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528728747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528728747?lang=zh_cn&edition=full","pubTime":"2025-04-17 23:26","pubTimestamp":1744903611,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日23时26分,Karyopharm Therapeutics Inc.股票出现异动,股价快速拉升6.11%。截至发稿,该股报4.69美元/股,成交量1.4123万股,换手率0.16%,振幅6.15%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.64%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417232652aa2c734c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417232652aa2c734c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","KPTI"],"gpt_icon":0},{"id":"2528227010","title":"Karyopharm Therapeutics Inc.盘中异动 大幅上涨5.75%报4.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528227010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528227010?lang=zh_cn&edition=full","pubTime":"2025-04-17 01:07","pubTimestamp":1744823224,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日01时07分,Karyopharm Therapeutics Inc.股票出现波动,股价大幅上涨5.75%。Karyopharm Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为1.12%。Karyopharm Therapeutics Inc.公司简介:Karyopharm Therapeutics Inc 是一家商业阶段的制药公司,开创了新型癌症疗法,致力于发现、开发和商业化针对核输出的药物,以治疗癌症和其他疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417010704973a29e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417010704973a29e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","LENZ","BK4139","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.karyopharm.com","stockEarnings":[{"period":"1week","weight":0.0364},{"period":"1month","weight":0.0364},{"period":"3month","weight":0.0606},{"period":"6month","weight":-0.5779},{"period":"1year","weight":-0.6848},{"period":"ytd","weight":-0.5515}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Karyopharm Therapeutics Inc.于2008年12月22日在特拉华州注册成立。该公司是一家临床阶段的制药公司,专注于发现和开发针对核转运靶点的新型一线药物,用于治疗癌症和重大疾病。该公司的科学专长集中在了解细胞核和细胞质之间细胞内运输的调节。该公司发现并开发了抑制核输出蛋白XPO1的全资、新型、小分子、核输出选择性抑制剂或SINE化合物。该公司的主要候选药物Selinexor(KPT-330)是一种XPO1抑制剂,正在多个开放标签的1期临床试验中接受评估,这些试验针对的是经过深度预处理的复发和难治性血液系统和实体瘤恶性肿瘤患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.007822},{"month":2,"riseRate":0.583333,"avgChangeRate":0.021466},{"month":3,"riseRate":0.583333,"avgChangeRate":0.056308},{"month":4,"riseRate":0.25,"avgChangeRate":-0.030056},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.043558},{"month":6,"riseRate":0.583333,"avgChangeRate":0.012026},{"month":7,"riseRate":0.5,"avgChangeRate":-0.012751},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.022599},{"month":9,"riseRate":0.545455,"avgChangeRate":-0.010356},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.034599},{"month":11,"riseRate":0.727273,"avgChangeRate":0.140432},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.102143}],"exchange":"NASDAQ","name":"Karyopharm Therapeutics Inc.","nameEN":"Karyopharm Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Karyopharm Therapeutics Inc.(KPTI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Karyopharm Therapeutics Inc.(KPTI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Karyopharm Therapeutics Inc.,KPTI,Karyopharm Therapeutics Inc.股票,Karyopharm Therapeutics Inc.股票老虎,Karyopharm Therapeutics Inc.股票老虎国际,Karyopharm Therapeutics Inc.行情,Karyopharm Therapeutics Inc.股票行情,Karyopharm Therapeutics Inc.股价,Karyopharm Therapeutics Inc.股市,Karyopharm Therapeutics Inc.股票价格,Karyopharm Therapeutics Inc.股票交易,Karyopharm Therapeutics Inc.股票购买,Karyopharm Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Karyopharm Therapeutics Inc.(KPTI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Karyopharm Therapeutics Inc.(KPTI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}